LoadingMutual fund
Tata Mutual Fund · Equity
Added
Largest addition
Anthem Biosciences Ltd.
shares +26643.3% · Healthcare
+₹33.3 cr
Fund Quality
Sector and thematic funds are not rated against diversified peers.
Broad accumulation across Chemicals and Healthcare.
Sector allocation, Feb 2026 → Aug 2026
New position
Aster DM Quality Care Ltd.
1.6% of the portfolio
+₹24.9 cr
Reduced
Largest reduction
Glaxosmithkline Pharmaceuticals Ltd.
shares −48.4% · Healthcare
−₹29.2 cr
Exited
Concord Biotech Ltd.
was 1.9% of the portfolio
−₹29.5 cr
Allocation change, Feb 2026 → Aug 2026, the same range as Capital Rotation.
Upgrade the plan to view this stock.Anthem Biosciences Ltd.ANTHEM
HealthcareUpgrade the plan to view this stock.Lupin Ltd.LUPIN
HealthcareUpgrade the plan to view this stock.Biocon Ltd.BIOCON
HealthcareApollo Hospitals Enterprise Ltd.APOLLOHOSP
HealthcareUpgrade the plan to view this stock.FDC LimitedFDC
HealthcareUpgrade the plan to view this stock.Fortis Healthcare Ltd.FORTIS
HealthcareUpgrade the plan to view this stock.Procter & Gamble Health LimitedPGHL
HealthcareAbbott India Ltd.ABBOTINDIA
HealthcareUpgrade the plan to view this stock.Sanofi Consumer Healthcare India LimitedSANOFICONR
HealthcareStocks this fund has persistently increased or reduced across its recent disclosures.
See where this fund has shifted portfolio exposure and which holdings drove those changes.
Disclosed holdings for August 2026. Change columns use share quantities, with earlier quantities adjusted when a corporate action has a usable ratio.
Sun Pharmaceutical Industries Ltd.SUNPHARMA | Healthcare | −₹37.9 L0.0% shares | 665.18K | 8.4% | +₹132 cr | Unchanged |
Upgrade the plan to view this stock.Healthcare Global Enterprises LimitedHCG | Healthcare | +₹8.3 cr0.0% shares | 1.34M | 6.3% | +₹98.6 cr | Unchanged |
Divi's Laboratories Ltd.DIVISLAB | Healthcare | −₹9.5 cr−23.2% shares | 93.47K | 5.7% | +₹88.5 cr | Reduced |
Abbott India Ltd.ABBOTINDIA | Healthcare | −₹1.7 cr+5.4% shares | 32.92K | 5.4% | +₹85.1 cr | Increased |
| Healthcare | −₹5.5 cr0.0% shares | 495.08K | 4.5% | +₹70.0 cr | Unchanged | |
Apollo Hospitals Enterprise Ltd.APOLLOHOSP | Healthcare | +₹7.5 cr+13.1% shares | 76.01K | 4.3% | +₹67.6 cr | Increased |
Cipla Ltd.CIPLA | Healthcare | −₹3.0 cr0.0% shares | 473.86K | 4.3% | +₹66.8 cr | Unchanged |
Upgrade the plan to view this stock.Dr. Reddy's Laboratories Ltd.DRREDDY | Healthcare | +₹35.9 L0.0% shares | 570.31K | 4.2% | +₹65.8 cr | Unchanged |
Max Healthcare Institute Ltd.MAXHEALTH | Healthcare | −₹3.2 cr0.0% shares | 571.48K | 3.8% | +₹59.6 cr | Unchanged |
Upgrade the plan to view this stock.Fortis Healthcare Ltd.FORTIS | Healthcare | +₹3.5 cr+11.8% shares | 569.35K | 3.3% | +₹51.6 cr | Increased |
Upgrade the plan to view this stock.Lupin Ltd.LUPIN | Healthcare | +₹10.3 cr+38.3% shares | 233.45K | 3.3% | +₹51.1 cr | Increased |
Upgrade the plan to view this stock.Syngene International Ltd.SYNGENE | Healthcare | +₹1.8 cr0.0% shares | 1.18M | 3.0% | +₹47.3 cr | Unchanged |
Upgrade the plan to view this stock.Bayer Cropscience Ltd.BAYERCROP | Chemicals | −₹3.1 cr0.0% shares | 118.82K | 3.0% | +₹47.2 cr | Unchanged |
Upgrade the plan to view this stock.Pfizer Ltd.PFIZER | Healthcare | −₹1.4 cr0.0% shares | 97.68K | 2.9% | +₹45.8 cr | Unchanged |
Upgrade the plan to view this stock.Mankind Pharma Ltd.MANKIND | Healthcare | −₹95.0 L0.0% shares | 188.40K | 2.9% | +₹45.6 cr | Unchanged |
Upgrade the plan to view this stock.Glaxosmithkline Pharmaceuticals Ltd.GLAXO | Healthcare | −₹29.2 cr−48.4% shares | 139.76K | 2.7% | +₹42.6 cr | Reduced |
Upgrade the plan to view this stock.Procter & Gamble Health LimitedPGHL | Healthcare | +₹2.0 cr+20.6% shares | 67.99K | 2.5% | +₹39.2 cr | Increased |
Upgrade the plan to view this stock.Sai Life Sciences Ltd.SAILIFE | Healthcare | −₹6.8 cr−23.8% shares | 258.08K | 2.4% | +₹37.7 cr | Reduced |
Upgrade the plan to view this stock.Alkem Laboratories Ltd.ALKEM | Healthcare | −₹2.9 cr0.0% shares | 69.06K | 2.4% | +₹36.8 cr | Unchanged |
Upgrade the plan to view this stock.Anthem Biosciences Ltd.ANTHEM | Healthcare | +₹33.3 cr+26643.3% shares | 374.41K | 2.1% | +₹33.4 cr | Increased |
Upgrade the plan to view this stock.FDC LimitedFDC | Healthcare | −₹3.9 cr+8.5% shares | 975.77K | 2.1% | +₹32.9 cr | Increased |
Upgrade the plan to view this stock.Global Health Ltd.MEDANTA | Healthcare | −₹6.6 cr−24.0% shares | 177.82K | 1.7% | +₹26.3 cr | Reduced |
Upgrade the plan to view this stock.Dr. Lal Path Labs Ltd.LALPATHLAB | Healthcare | −₹7.5 cr−23.7% shares | 134.22K | 1.7% | +₹26.0 cr | Reduced |
Aster DM Quality Care Ltd.ASTERDM | Healthcare | +₹24.9 cr— | 329.71K | 1.6% | +₹24.9 cr | New |
Upgrade the plan to view this stock.Sumitomo Chemical India Ltd.SUMICHEM | Chemicals | +₹34.3 L0.0% shares | 479.95K | 1.6% | +₹24.8 cr | Unchanged |
Upgrade the plan to view this stock.Ajanta Pharmaceuticals Ltd.AJANTPHARM | Healthcare | +₹93.0 L0.0% shares | 68.05K | 1.6% | +₹24.5 cr | Unchanged |
Acutaas Chemicals Ltd.ACUTAAS | Healthcare | +₹23.2 cr— | 73.40K | 1.5% | +₹23.2 cr | New |
Upgrade the plan to view this stock.Manipal Health Enterprises LimitedMANIPALHOS | Healthcare | +₹4.4 cr0.0% shares | 253.50K | 1.2% | +₹19.3 cr | Unchanged |
Upgrade the plan to view this stock.Metropolis Healthcare LimitedMETROPOLIS | Healthcare | −₹30,0000.0% shares | 297.35K | 1.1% | +₹17.3 cr | Unchanged |
Upgrade the plan to view this stock.Gillette India Ltd.GILLETTE | Fast Moving Consumer Goods | −₹72.6 L−0.2% shares | 23.24K | 1.1% | +₹17.0 cr | Reduced |
Upgrade the plan to view this stock.Biocon Ltd.BIOCON | Healthcare | +₹7.5 cr+100.7% shares | 376.34K | 1.0% | +₹15.5 cr | Increased |
Upgrade the plan to view this stock.PI Industries Ltd.PIIND | Chemicals | +₹14.9 cr— | 63.07K | 0.9% | +₹14.9 cr | New |
Upgrade the plan to view this stock.Ipca Laboratories Ltd.IPCALAB | Healthcare | +₹14.1 cr— | 71.54K | 0.9% | +₹14.1 cr | New |
Upgrade the plan to view this stock.Molbio Diagnostics LimitedMOLBIO | Healthcare | +₹13.7 cr— | 125.80K | 0.9% | +₹13.7 cr | New |
Upgrade the plan to view this stock.Dr. Agarwal's Health Care LimitedAGARWALEYE | Healthcare | +₹75.8 L0.0% shares | 215.22K | 0.7% | +₹11.0 cr | Unchanged |
Upgrade the plan to view this stock.Symbiotec Pharmalab LimitedSYMBIOTEC | Healthcare | +₹10.0 cr— | 101.22K | 0.6% | +₹10.0 cr | New |
Upgrade the plan to view this stock.Sanofi Consumer Healthcare India LimitedSANOFICONR | Healthcare | −₹25.5 L+8.0% shares | 19.84K | 0.5% | +₹8.2 cr | Increased |
HDFC Life Insurance Company Ltd.HDFCLIFE | Financial Services | +₹7.9 cr— | 145.06K | 0.5% | +₹7.9 cr | New |
Upgrade the plan to view this stock.Zim Laboratories LimitedZIMLAB | Healthcare | +₹61.2 L0.0% shares | 631.19K | 0.5% | +₹7.7 cr | Unchanged |
Upgrade the plan to view this stock.Jubilant Pharmova Ltd.JUBLPHARMA | Healthcare | −₹8.8 cr−66.9% shares | 45.05K | 0.3% | +₹4.0 cr | Reduced |
Torrent Pharmaceuticals Ltd.TORNTPHARM | Healthcare | +₹1.9 cr— | 3.74K | 0.1% | +₹1.9 cr | New |
Upgrade the plan to view this stock.BASF India LimitedBASF | Chemicals | −₹14.9 cr−100.0% shares | 0 | — | ₹0 | Exited |
Upgrade the plan to view this stock.Concord Biotech Ltd.CONCORDBIO | Healthcare | −₹29.5 cr−100.0% shares | 0 | — | ₹0 | Exited |
Upgrade the plan to view this stock.Neuland Laboratories Ltd.NEULANDLAB | Healthcare | −₹19.3 cr−100.0% shares | 0 | — | ₹0 | Exited |
Upgrade the plan to view this stock.Sanofi India LimitedSANOFI | Healthcare | −₹3.5 cr−100.0% shares | 0 | — | ₹0 | Exited |
See where this fund has shifted portfolio exposure and which holdings drove those changes.
Over the last 6 months, the fund's largest allocation increase was in Chemicals (+2.2 pp).
Sectors with the largest changes in portfolio allocation over the selected period.
See which holdings gained or lost exposure within the selected sector.
Within Chemicals, Sumitomo Chemical India Ltd. (new position) and PI Industries Ltd. (new position) saw the largest disclosed position increases.
Ribbon width is the notional size of each disclosed share change: shares added or removed, valued at the Aug 2026 reference price. Ribbons join each holding to the sector, not to other holdings; disclosures do not show which sale funded which purchase.
Allocation change is the percentage-point change in each sector's share of the disclosed portfolio, and can move with prices as well as trades. Position changes compare corporate-action adjusted share quantities at the two disclosures; a change under 0.5% of the existing holding counts as unchanged. Holdings without a sector classification are grouped as Unclassified.
Stocks this fund has persistently increased or reduced across its recent disclosures.
13 holdings show persistent accumulation5 show persistent reduction23 are mixed or stableAug 2025 – Aug 2026 · 12 comparable transitions
Abbott India Ltd.ABBOTINDIA
HealthcareIncreased in 9 of 11 comparable transitions
6 consecutive increasesEntered Sept 2025Portfolio weight 5.4%
Upgrade the plan to view this stock.Syngene International Ltd.SYNGENE
HealthcareIncreased in 8 of 12 comparable transitions
5 consecutive increasesPortfolio weight 3.0%
Upgrade the plan to view this stock.FDC LimitedFDC
HealthcareIncreased in 8 of 12 comparable transitions
4 consecutive increasesPortfolio weight 2.1%
Rainbow Childrens Medicare Ltd.RAINBOW
HealthcareIncreased in 8 of 12 comparable transitions
3 consecutive increasesPortfolio weight 4.5%
Upgrade the plan to view this stock.Glaxosmithkline Pharmaceuticals Ltd.GLAXO
HealthcareIncreased in 7 of 9 comparable transitions
7 consecutive increasesEntered Nov 2025Portfolio weight 2.7%
Upgrade the plan to view this stock.PI Industries Ltd.PIIND
ChemicalsReduced in 4 of 6 comparable transitions
3 consecutive reductionsEntered Aug 2026Portfolio weight 0.9%
Upgrade the plan to view this stock.CORONA Remedies LimitedCORONA
HealthcareReduced in 3 of 5 comparable transitions
Entered Dec 2025Exited Jun 2026
Upgrade the plan to view this stock.Neuland Laboratories Ltd.NEULANDLAB
HealthcareReduced in 3 of 6 comparable transitions
3 consecutive reductionsEntered Jan 2026Exited Aug 2026
Aster DM Quality Care Ltd.ASTERDM
HealthcareReduced in 2 of 3 comparable transitions
Entered Aug 2026Portfolio weight 1.6%
Upgrade the plan to view this stock.Wockhardt Ltd.WOCKPHARMA
HealthcareReduced in 2 of 4 comparable transitions
Exited Jan 2026
Conviction signal based on persistent disclosed position changes. Bars show each stock's disclosed share quantity scaled to its own first holding in the range (not portfolio weight), adjusted for splits and bonuses. A move under 0.5% of the existing holding counts as stable.